Medine.co.uk

Levetiracetam Teva 100 Mg/Ml Oral Solution

Levetiracetam Teva 100 mg/ml Oral Solution


PACKAGE LEAFLET: INFORMATION FOR THE USER


Read all of this leaflet carefully before you or your child start taking this medicine because it contains important information for you.

-    Keep this leaflet. You may need to read it again.

-    If you have any further questions, ask your doctor or pharmacist.

-    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

-    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.


1    What Levetiracetam Teva 100 mg/ml oral solution is and what it is used for

2    What you need to know before you take Levetiracetam Teva 100 mg/ml oral solution

3    How to take Levetiracetam Teva 100 mg/ml oral solution


4    Possible side effects

5    How to store Levetiracetam Teva 100mg/ml oral solution

6    Contents of the pack and other information


OWhat Levetiracetam Teva 100 mg/ml Oral Solution is and what it is used for


Levetiracetam Teva 100 mg/ml oral solution is an antiepileptic medicine (a medicine used to treat seizures in epilepsy).

Levetiracetam Teva is used:

•    on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat a certain form of epilepsy. Epilepsy is a condition where the patients have repeated fits (seizures). Levetiracetam is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain (partial onset seizure with or without secondary generalisation). Levetiracetam has been given to you by your doctor to reduce the number of fits.

•    as an add-on to other antiepileptic medicines to treat:

-    partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age

-    myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy

-    primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).


parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).

Levetiracetam Teva oral solution also contains maltitol. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

©How to take Levetiracetam Teva 100 mg/ml Oral Solution

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Take the oral solution following your doctor's instructions.

Levetiracetam Teva must be taken twice a day, once in the morning and once in the evening, at about the same time each day.

Monotherapy

Dose in adults and adolescents (From 16 years of age): General dose: between 10 ml (1,000 mg) and 30 ml (3,000 mg) each day, divided in 2 intakes per day. When you first start taking Levetiracetam Teva, your doctor will prescribe you a lower dose for 2 weeks before giving you the lowest general dose. Add-on therapy

Dose in adults and adolescents aged 12 to 17 years weighing 50 kg or more:

General dose: between 10 ml (1,000 mg) and 30 ml (3,000 mg) each day, divided in 2 intakes per day. Dose in infants aged 1 month to 23 months, children aged 2 to 11 years and adolescents aged 12 to 17


pharmaceutical form of Levetiracetam according to the age, weight and dose.

Oral solution is a formulation more appropriate to infants and children under the age of 6 years and to children and adolescent (from 6 to 17 years)

allow accurate dosage.

General dose: between 0.2 ml (20 mg) and 0.6 ml (60 mg) per kg bodyweight each day, divided in 2 intakes per day. The exact quantity of oral solution formulation should be measured using the syringe (provided in the cardboard box) and then emptying the contents of the syringe into either a glass of water or baby's bottle.


3


What you need to know before you take Levetiracetam Teva 100 mg/ml Oral Solution


Do not take Levetiracetam Teva

If you are allergic to levetiracetam, pyrrolidone derivatives or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking this

medicine:

•    if you suffer from kidney problems, follow your doctor's instructions. He/she may decide if your dose should be adjusted.

•    if you notice any slow down in the growth or unexpected puberty development of your child, please contact your doctor.

•    a small number of people being treated with anti-epileptics such as Levetiracetam Teva have had thoughts of harming or killing themselves. If you have any symptoms of depression and/or suicidal ideation, please contact your doctor.

Children and adolescents


Children 25 kg or less should start the treatment with Levetiracetam Teva 100 mg/ml oral solution Dose in children and adolescents 50 kg or more is the same as in adults

Dose in infants aged 1 month to less than 6 months:

General dose: between 0.14 ml (14 mg) and 0.42 ml (42 mg) per kg bodyweight each day, divided in 2 intakes per day. The exact quantity of oral solution formulation should be measured using the syringe provided in the cardboard box and then emptying the contents of the syringe into either a glass of water or baby's bottle.


• Levetriacetam Teva is not indicated in children and adolescents below 16 years on its own (monotherapy).

Other medicines and Levetiracetam Teva

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Do not take macrogol (a drug used as laxative) for one hour before and one hour after taking levetiracetam as this may result in a loss of its effect.

Pregnancy and breast-feeding If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Levetiracetam Teva should not be used during pregnancy unless clearly necessary. A risk of birth defects for your unborn child cannot be completely excluded. Levetiracetam Teva has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures. Breast-feeding is not recommended during treatment Driving and using machines

Levetiracetam Teva may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy. This is more likely at the beginning of treatment or after an increase in the dose. You should not drive or use machines until it is established that your ability to perform such activities is not affected.

Levetiracetam Teva 100 mg/ml oral solution contains methyl parahydroxybenzoate, propyl parahydroxybenzoate and maltitol

Levetiracetam Teva oral solution includes methyl parahydroxybenzoate (E218) and propyl



Method of administration:

Levetiracetam Teva oral solution may be diluted in a glass of water or baby's bottle. You may take Levetiracetam with or without food.

Instructions for use:

•    Open the bottle: press the cap and turn it anticlockwise (figure 1).

•    Insert the syringe adaptor into the bottle neck (figure 2). Ensure it is well fixed.

•    Take the syringe and put it in the adaptor opening (figure 2).

•    Turn the bottle upside down (figure 3).

•    Fill the syringe with a small amount of solution by pulling the piston down (figure 4), then push the piston upward in order to remove any possible bubbles (figure 5). Pull the piston down to the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (figure 6).


Weight

Starting dose: 0.1 ml/kg twice daily

Maximum dose: 0.3 ml/kg twice daily

6 kg

0.6 ml twice daily

1.8 ml twice daily

8 kg

0.8 ml twice daily

2.4 ml twice daily

10 kg

1 ml twice daily

3 ml twice daily

15 kg

1.5 ml twice daily

4.5 ml twice daily

20 kg

2 ml twice daily

6 ml twice daily

25 kg

2.5 ml twice daily

7.5 ml twice daily

From 50 kg

5 ml twice daily

15 ml twice daily


Weight

Starting dose: 0.07 ml/kg twice daily

Maximum dose: 0.21 ml/kg twice daily

4 kg

0.3 ml twice daily

0.85 ml twice daily

5 kg

0.35 ml twice daily

1.05 ml twice daily

6 kg

0.45 ml twice daily

1.25 ml twice daily

7 kg

0.5 ml twice daily

1.5 ml twice daily



Turn the bottle the right way up.

Remove the syringe from the adaptor.

Empty the contents of the syringe into a glass of water or baby's bottle by pushing the piston to the bottom (figure 7).

Drink the whole contents of the glass / baby's bottle

Close the bottle with the plastic screw cap.

Wash the syringe with water only (figure 8).

Duration of treatment:

Levetiracetam Teva is used as a chronic treatment. You should continue Levetiracetam Teva treatment for as long as your doctor has told you.

Do not stop your treatment without your doctor's advice as this could increase your seizures.

If you take more Levetiracetam Teva than you should:

The possible side effects of an overdose of Levetiracetam Teva are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.

Contact your doctor if you took more Levetiracetam Teva than you should. Your doctor will establish the best possible treatment for an overdose.

If you forget to take Levetiracetam Teva:

Contact your doctor if you have missed one or more

Do not take a double dose to make up for a forgotten dose.

If you stop taking Levetiracetam Teva:

Do not stop your treatment without your doctor's advice as this could increase your seizures.

If stopping treatment, Levetiracetam Teva should be discontinued gradually to avoid an increase of seizures.

Should your doctor decide to stop your Levetiracetam Teva treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam Teva.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

^ Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You should go to Accident and Emergency immediately if you experience symptoms of;

•    serious allergic reaction that may begin with a skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme)

•    a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome)

•    a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis)

•    a rash, fever, inflammation of internal organ and blood abnormalities including an increase in white blood cells (DRESS syndrome).

You should contact your doctor immediately if you experience symptoms of severe abdominal and back pain accompanied with feeling very unwell (pancreatitis) or hepatic failure.

You should see your doctor immediately if you experience depression, emotional instability/mood swings, or suicidal thoughts or behaviour.

You should also seek medical attention if you experience a hypersensitivity reaction (for example itching, rash, hives, difficulty breathing).

Some of the side effects like sleepiness, tiredness and dizziness may be more common at the beginning of the treatment or at dose increase. These effects should however decrease over time. Very common: may affect more than 1 in 10 people

•    nasopharyngitis (cough, sore throat, runny nose and fever)

•    somnolence (sleepiness); headache.

Common: may affect up to 1 to 10 users in 100 people

•    anorexia (loss of appetite)

•    hostility or aggression, anxiety, insomnia, nervousness or irritability

•    convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling)

•    vertigo (sensation of rotation)

•    cough

•    abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea

•    rash

•    asthenia/fatigue (tiredness).

Uncommon: may affect 1 to 10 users in 1000 people

•    decreased number of blood platelets, decreased number of white blood cells

•    weight decrease, weight increase

•    suicide attempt, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, agitation

•    amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration)

•    diplopia (double vision), vision blurred

•    elevated/abnormal values in a liver function test

•    hair loss, eczema, pruritus

•    muscle weakness, myalgia (muscle pain)

•    injury.

Rare: may affect 1 to 10 users in 10,000 people

•    infection

•    decreased number of all blood cell types

•    severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction], Quincke's oedema [swelling of the face, lips, tongue and throat]);

•    suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate)

•    uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity)

•    liver failure ,hepatitis

•    Low blood levels of sodium which can cause tiredness and confusion, muscle twitching, fits or coma.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

0How to store Levetiracetam Teva 100mg/ml Oral Solution

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the cardboard box and bottle after EXP. The expiry date refers to the last day of the month. Do not use after 7 months of first opening the bottle. Due to sensitivity to light, store in the original container.

Store in an upright position.

Do not thorw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

Contents of the pack and other information

What Levetiracetam Teva 100 mg/ml oral solution contains

The active substance is levetiracetam. Each ml contains 100 mg of levetiracetam.

The other ingredients are:

Sodium citrate

Citric acid monohydrate

Methyl parahydroxybenzoate (E218)

Propyl parahydroxybenzoate (E216)

Ammonium glycyrrhizate Glycerol (E422)

Maltitol liquid (E965)

Acesulfame potassium (E950)

Grapefruit flavour Purified water

What Levetiracetam Teva 100 mg/ml oral solution looks like and contents of the pack

Levetiracetam Teva 100 mg/ml oral solution is a clear liquid.

50 ml solution (sample pack) in an amber glass bottle with a white child resistant closure in a cardboard box also containing a 1 ml oral syringe (graduated every 0.05 ml) and an adaptor for the syringe.

150 ml solution in an amber glass bottle with a white child resistant closure (for infants aged 1 month to less than 6 months) in a cardboard box also containing a 1 ml oral syringe (graduated every 0.05 ml) and an adaptor for the syringe.

150 ml solution in an amber glass bottle with a white child resistant closure (for infants and young children aged from 6 months to less than 4 years) in a cardboard box also containing a 3 ml oral syringe (graduated every 0.1 ml) and an adaptor for the syringe.

300 ml solution in an amber glass bottle with a white child resistant closure (for children aged 4 years and above, adolescents and adults) in a cardboard box also containing a 10 ml oral syringe (graduated every 0.25 ml) and an adaptor for the syringe.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Teva UK Limited

Eastbourne

BN22 9AG

United Kingdom

Manufacturer

Bluepharma Industria Farmaceutica, S.A.

S. Martinho de Bispo 3045-016 Coimbra

This leaflet was last revised in 06/2016

PL 00289/1703

64216-D

WAUKLIIIT'D    154 X 420